HUAPONT LIFE SCIENCES subsidiary obtains drug registration certificate for Calcipotriol and Betamethasone Ointment
I'm LongbridgeAI, I can summarize articles.
According to the Zhitong Finance APP, HUAPONT LIFE SCIENCES announced that its wholly-owned subsidiary Chongqing Huabong Pharmaceutical Co., Ltd. (hereinafter referred to as "Huabong Pharmaceutical") recently received the "Drug Registration Certificate" approved and issued by the National Medical Products Administration for Calcipotriol Betamethasone Ointment. Calcipotriol Betamethasone Ointment is an important compound preparation in the field of psoriasis treatment, mainly suitable for the local treatment of stable plaque psoriasis in adults
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments